<SEC-DOCUMENT>0001415889-25-005913-index.html : 20250227 <SEC-HEADER>0001415889-25-005913.hdr.sgml : 20250227 <ACCEPTANCE-DATETIME>20250227184339 ACCESSION NUMBER: 0001415889-25-005913 CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250227 DATE AS OF CHANGE: 20250227 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Oruka Therapeutics, Inc. CENTRAL INDEX KEY: 0000907654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 363855489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-51477 FILM NUMBER: 25681634 BUSINESS ADDRESS: STREET 1: 855 OAK GROVE AVE. STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-606-7910 MAIL ADDRESS: STREET 1: 855 OAK GROVE AVE. STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: ARCA biopharma, Inc. DATE OF NAME CHANGE: 20090128 FORMER COMPANY: FORMER CONFORMED NAME: NUVELO INC DATE OF NAME CHANGE: 20030203 FORMER COMPANY: FORMER CONFORMED NAME: HYSEQ INC DATE OF NAME CHANGE: 19970610 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Venrock Healthcare Capital Partners III, L.P. CENTRAL INDEX KEY: 0001738048 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A BUSINESS ADDRESS: STREET 1: 530 FIFTH AVENUE, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-444-4100 MAIL ADDRESS: STREET 1: 530 FIFTH AVENUE, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G/A <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ex-99-02272025_110242.htm <DESCRIPTION>JOINT FILING AGREEMENT <TEXT> Document 2 - file: ex-99-02272025_110242.htm
</DOCUMENT> </SEC-DOCUMENT>